XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Stock Options and Restricted Stock Units (Tables)

6 Months Ended

Jun. 30, 2024

Stock Options and Restricted Stock Units

Schedule of stock-based compensation expense

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Six Months Ended

​

​

June 30,

​

June 30,

​

2024

2023

2024

2023

Direct operating costs

​

$

73

​

$

62

​

$

157

​

$

126

Selling and administrative expenses

​

919

​

957

​

1,869

​

1,855

Total stock-based compensation

​

$

992

​

$

1,019

​

$

2,026

​

$

1,981

Schedule of weighted-average fair value of the options granted, and weighted-average assumptions

​

​	​	​	​	​	​	​	​
​	​	For the Six Months Ended June 30,					​
​		2024			2023		​
Weighted average fair value of options granted	​	$	-	​	$	1.79	​
Risk-free interest rate	​	​	-	​	​	3.88	%
Expected term (years)	​	​	-	​	​	3.0	​
Expected volatility factor	​	​	-	​	​	79.95	%
Expected dividends	​	​	-	​	​	-	​

Equity Plans

Stock Options and Restricted Stock Units

Schedule of stock option activity

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​			Weighted-Average		​
​	​	Number of		Weighted - Average			Remaining Contractual	​	Aggregate
​		Options		Exercise Price			Term (years)		Intrinsic Value
Outstanding at January 1, 2024		5,339,162	​	$	3.22		6.38		$	28,640,009
Granted		-	​		-		-		​	-
Exercised		(155,899)	​		4.00		-		​	-
Forfeited/Expired		(4,001)	​		6.96		-		​	-
Outstanding at June 30, 2024		5,179,262	​	$	3.19		5.87	​	$	60,291,271
​		​	​		​		​	​		​
Exercisable at June 30, 2024		3,402,382	​	$	2.20	​	4.92	​	$	42,967,259
​		​	​		​		​	​		​
Vested and Expected to Vest at June 30, 2024		5,179,262	​	$	3.19		5.87	​	$	60,291,271

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​	​		Weighted-Average		​	​
​	​	Number of	​	Weighted - Average		​	Remaining Contractual	​	Aggregate
​	​	Options	​	Exercise Price		​	Term (years)	​	Intrinsic Value
Outstanding at January 1, 2023	​	6,690,490	​	$	3.09	​	7.19	​	$	5,989,709
Granted*		25,000		​	3.31		-		​	-
Exercised		(871,884)		​	2.34		-		​	-
Forfeited/Expired		(75,766)		​	6.96		-		​	-
Outstanding at June 30, 2023		5,767,840	​	$	3.16		6.84	​	$	47,137,674
​	​	​	​	​	​	​	​	​	​	​
Exercisable at June 30, 2023		3,600,261	​	$	1.91		5.73	​	$	33,897,858
​	​	​	​	​	​	​	​	​	​	​
Vested and Expected to Vest at June 30, 2023		5,767,840	​	$	3.16		6.84	​	$	47,137,674

​

* Granted to a non-employee member of the Company’s advisory board.

​

​	​	​	​	​	​	​	​	​	​	​
​	​	​	​	​		​	Weighted-Average	​	​
​	​	Number of	​	Weighted - Average		​	Remaining Contractual	​	Aggregate
​		Options		Exercise Price			Term (years)		Intrinsic Value
Outstanding at January 1, 2024		923,571	​	$	3.41		8.76		$	4,786,252
Granted		-	​		-		-		​	-
Exercised		(46,430)	​		3.41		-		​	-
Forfeited/Expired		(7,668)	​		3.41		-		​	-
Outstanding at June 30, 2024		869,473	​	$	3.41		8.27	​	$	9,927,362
​	​	​	​	​	​	​	​	​	​	​
Exercisable at June 30, 2024		339,779	​	$	3.33		8.24	​	$	3,907,176
​	​	​	​	​	​	​	​	​	​	​
Vested and Expected to Vest at June 30, 2024		869,473	​	$	3.41		8.27	​	$	9,927,362

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​	​		Weighted-Average		​	​
​	​	Number of	​	Weighted - Average		​	Remaining Contractual	​	Aggregate
​	​	Options	​	Exercise Price		​	Term (years)	​	Intrinsic Value
Outstanding at January 1, 2023		1,027,500	​	$	3.46		9.75		$	-
Granted		-	​		-		-		​	-
Exercised		(25,000)	​		6.40		-		​	-
Forfeited/Expired		(42,000)	​		3.41		-		​	-
Outstanding at June 30, 2023		960,500	​	$	3.38		9.27	​	$	7,634,060
​	​	​	​	​	​	​	​	​	​	​
Exercisable at June 30, 2023		18,750	​	$	3.39		9.21	​	$	148,875
​	​	​	​	​	​	​	​	​	​	​
Vested and Expected to Vest at June 30, 2023		960,500	​	$	3.38		9.27	​	$	7,634,060

Restricted Stock Units

Stock Options and Restricted Stock Units

Summary of restricted stock under the company's plan

​

​	​	​	​	​	​
​	​	Number of		Weighted-Average
​	​	Restricted Stock	​	Grant Date
​		Units		Fair Value
Unvested at January 1, 2024	​	749,756	​	$	5.77
Granted		28,973		​	15.10
Vested		(48,761)		​	8.42
Forfeited/Expired		(995)		​	8.29
Unvested at June 30, 2024		728,973	​	$	5.96

​

​	​	​	​	​	​
​		Number of		Weighted-Average
​	​	Restricted Stock	​	Grant Date
​	​	Units	​	Fair Value
Unvested at January 1, 2023		700,000	​	$	5.59
Granted		28,804	​		8.29
Vested		-	​		-
Forfeited/Expired		-	​		-
Unvested at June 30, 2023		728,804	​	$	5.70

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	inod_StockOptionsLineItems
Namespace Prefix:	inod_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_PlanNameAxis=inod_EquityPlansMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: